Conditions: Acute Uncomplicated Falciparum Malaria
Keywords: plasmodium P. falciparum malaria infant neonate
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
The purpose of the study is to obtain efficacy, safety and pharmacokinetic (PK) data following treatment with artemether-lumefantrine dispersible tablet in infants \< 5 kg of body weight (BW) with uncomplicated falciparum malaria.

Detailed description:

Arms:
arm 1: One Artemether-lumefantrine (COA566) dispersible tablet taken orally twice a day during 3 days.

Infants age \>28 days.

Interventions: intervention 1: Artemether-lumefantrine (COA566)
Intervention descriptions: intervention 1: One dispersible tablet taken orally twice a day during 3 days.

Protocol document: